Tuesday, 17 November 2026European Markets

OXURION Stock Went Up By Over 25% At Session Start On Wednesday

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(VIANEWS) - Shares of OXURION (BEL 20: OXUR.BR) rose by a staggering 25.71% to 0.02 € at 10:25 EST on Wednesday, after four consecutive sessions in a row of losses. BEL 20 is jumping 1.23% to 3,920.71 €, after three sequential sessions in a row of losses. This seems, as yet, an all-around bullish trend trading session today.

OXURION's last close was 0.02 €, 99.2% under its 52-week high of 1.95 €.

About OXURION

Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Its lead product is JETREA for the treatment of vitreomacular adhesion/vitreomacular traction. The company also develops THR-149, a plasma kallikrein inhibitor, which is in Phase II clinical trials for the treatment of diabetic macular edema (DME); and THR-687, an integrin antagonist which is in Phase II clinical trials for the treatment of DME. It has collaboration agreements with Bicycle Therapeutics, INC Research, and Galapagos NV. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.

Earnings Per Share

As for profitability, OXURION has a trailing twelve months EPS of -0.732 €.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -694.15%.

Volume

Today's last reported volume for OXURION is 11010595 which is 57.63% below its average volume of 25989200.

Moving Average

OXURION's value is above its 50-day moving average of 0.02 € and way below its 200-day moving average of 0.24 €.

Volatility

OXURION's last week, last month's, and last quarter's current intraday variation average was a negative 5.71%, a negative 2.85%, and a positive 12.84%.

OXURION's highest amplitude of average volatility was 5.71% (last week), 7.00% (last month), and 12.84% (last quarter).

Yearly Top and Bottom Value

OXURION's stock is valued at 0.02 € at 10:25 EST, way under its 52-week high of 1.95 € and way above its 52-week low of 0.01 €.

More news about OXURION (OXUR.BR).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

Spotted an error? Use “Correct this article” (bottom right), or select any sentence, to report it or respond to that point.

  1. Published before we listed source documents with each article.
  2. Published 8 Feb 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›